Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T15:32:43.105Z.
Calculation as of: 2026-10-06T15:32:43.105Z.
Quote observation: 2026-10-06T15:31:28.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e7bb4fe4bb3aa983eb4620adc8aa5d0f555a5020ff21ce65ee2b72f9631e0f85
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Dyne Therapeutics, Inc.
Market Cap
$2.89B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.82B
Free Cash Flow Yield
2.80%
TTM Avg
3.13%
3Y Avg
2.70%
5Y Avg
2.70%
Market Cap
$2.75B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.70B
Free Cash Flow Yield
N/A
TTM Avg
0.77%
3Y Avg
2.82%
5Y Avg
3.32%
Market Cap
$3.09B
Free Cash Flow Yield
1.27%
TTM Avg
0.97%
3Y Avg
0.97%
5Y Avg
0.97%
Market Cap
$3.09B
Free Cash Flow Yield
N/A
TTM Avg
9.18%
3Y Avg
9.18%
5Y Avg
9.18%
Market Cap
$2.69B
Free Cash Flow Yield
5.88%
TTM Avg
5.78%
3Y Avg
3.95%
5Y Avg
3.33%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.89B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.82B | 2.80% | 3.13% | 2.70% | 2.70% |
| AtriCure, Inc. (ATRC)vs › | $2.79B | 1.84% | 2.05% | 1.80% | 1.80% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.75B | N/A | N/A | N/A | N/A |
| Precigen, Inc. (PGEN)vs › | $2.73B | N/A | 0.67% | 0.67% | 0.67% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | N/A | 0.77% | 2.82% | 3.32% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.09B | 1.27% | 0.97% | 0.97% | 0.97% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | N/A | 9.18% | 9.18% | 9.18% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 5.88% | 5.78% | 3.95% | 3.33% |
| Neogen Corporation (NEOG)vs › | $2.69B | N/A | 0.48% | 1.33% | 1.45% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
